Center for Scientific Review; Notice of Closed Meetings, 71370-71371 [2023-22770]
Download as PDF
<![CDATA[
ddrumheller on DSK120RN23PROD with NOTICES1
71370
Federal Register / Vol. 88, No. 198 / Monday, October 16, 2023 / Notices
updates: https://ncvhs.hhs.gov/
meetings/full-committee-meeting-15.
Background on ICD–11: The
International Classification of Diseases
(ICD) is the global standard for health
data, clinical documentation, and
statistical aggregation. It provides a
common language for recording,
reporting, and monitoring diseases,
allowing the world to compare and
share data in a consistent and standard
way—among hospitals, regions, and
countries, and over periods of time. It
facilitates the collection and storage of
data for analysis and evidence-based
decision-making by enabling systematic
recording, reporting, analysis,
interpretation, and comparison of
mortality and morbidity data.
ICD–11 allows countries to count and
identify their most pressing health
issues using an up-to-date and clinically
relevant classification system.3 4 5 6
Governments assign ICD–11 codes to
health conditions and accidents so data
can be used to design effective public
health policies and measure their
impacts, or so that clinicians can use the
data for recording encounters with
patients in a standard way.
Request for Information: This Notice
also serves as a Request for Information
(RFI) addressing the potential use of
ICD–11 for morbidity coding in the U.S.
We welcome responses from industry
stakeholders, interested individuals and
organizations, or any members of the
public. The following questions are a
guide to information the Workgroup
would find particularly helpful, though
respondents are invited to comment on
any aspect of ICD–11 that they wish.
and improve quality/accuracy through
the greater automation offered by the
ICD–11 online classification systems?
a. How might automation reduce burdens
of clinical documentation and coding for
reimbursement, risk adjustment, clinical
registry, and public health reporting?
b. What might be the role of artificial
intelligence for your organization?
c. What might be the role of standardized
cross-maps to other coding systems?
d. What other potential features could
promote burden reduction?
3. What standards, systems, workforce, and
processes must change to accommodate
ICD–11?
a. How would your organization assess the
cost and impact of these changes?
b. How might technical changes such as
clustered (post-coordinated) coding be
implemented in your environment?
c. What other changes are related?
4. What are the most important
considerations and requirements for a
U.S. governing body for ICD–11?
a. Developing and managing
implementation plans and programs for
ICD–11 in the U.S.
b. Developing regulations or guidance for
ICD–11 applicable to your organization.
c. Ongoing management and maintenance
of U.S. ICD–11 and its use.
d. Other requirements not named above?
5. What financial, educational, or human
resources will be needed for:
a. Implementing ICD–11 in your
organization.
b. Managing and maintaining U.S. ICD–11
in your organization.
c. Meeting the needs of smaller, less
resourced, or less externally supported
entities.
d. What other resources not listed here may
be needed?
1. Related to ICD–11 content and addressing
U.S.-specific needs, which
enhancements in classification content
would be most useful?
a. Coding to assess and address population
health equity, social, behavioral, and
community health
b. Coding to measure health care quality
and patient safety
c. Coding for rare diseases
d. Content on other topics?
2. What is the potential to reduce burdens
The Committee will compile
submitted responses and consider them
together with responses submitted in
response to the initial ICD–11 RFI
[https://ncvhs.hhs.gov/wp-content/
uploads/2023/07/RFI-ResponsesNCVHS-Workgroup-on-Timely-andStrategic-Action-to-Inform-ICD-11Policy.pdf] together with input from
subject matter experts during the August
3, 2023, ICD–11 Expert Roundtable
meeting [https://ncvhs.hhs.gov/
meetings/icd-11-workgroup-meeting/].
To submit comments in response to the
RFI, please send by January 12, 2024, to
NCVHSmail@cdc.gov and include on
the subject line: Response from [your
organization or name] regarding ICD–11
RFI.
3 ICD–11 Overview: Key Facts, History, and
References (September 2023): https://
ncvhs.hhs.gov/NCVHS-WG-ICD-11-OverviewSeptember-2023.
4 ICD–11 was adopted at the World Health
Assembly in May 2019 and Member States
committed to start using it for mortality and
morbidity reporting in 2022. Since 2019, early
adopter countries, translators, and scientific groups
have recommended further refinements to produce
the version that is posted online today. World
Health Organization (WHO) Press Release.
(February 11, 2022): https://paho.org/en/news/11-22022-whos-new-international-classificationdiseases-icd-11-comes-effect.
5 WHO ICD–11 website: https://icd.who.int/en.
6 WHO ICD–11 Fact Sheet: https://icd.who.int/en/
docs/icd11factsheet_en.pdf.
VerDate Sep<11>2014
17:03 Oct 13, 2023
Jkt 262001
Sharon Arnold,
Associate Deputy Assistant Secretary, Office
of Science and Data Policy, Office of the
Assistant Secretary for Planning and
Evaluation.
[FR Doc. 2023–22753 Filed 10–13–23; 8:45 am]
BILLING CODE 4150–05–P
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Neurodegenerative Disorders and
Aging.
Date: November 7, 2023.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jessica Bellinger, Ph.D.,
Scientific Review Administrator, Center for
Scientific of Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3158,
Bethesda, MD 20892, 301–827–4446,
bellingerjd@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Fellowships: Genes, Genomes and Genetics.
Date: November 8–9, 2023.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Bethesdan Hotel, 8120
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Linda Wagner Jurata,
Ph.D., Scientific Review Officer, The Center
for Scientific Review, The National Institutes
of Health, 6701 Rockledge Drive, Bethesda,
MD 20892, (301) 496–8032, linda.jurata@
nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Biomedical Sensing, Measurement
and Instrumentation.
Date: November 8–9, 2023.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Steven Anthony Ripp,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 594–3010, steven.ripp@nih.gov.
E:\FR\FM\16OCN1.SGM
16OCN1
Federal Register / Vol. 88, No. 198 / Monday, October 16, 2023 / Notices
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR Panel:
Alzheimer’s Disease and its Related
Dementias.
Date: November 8–9, 2023.
Time: 9:30 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Mariam Zaka, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1009J,
Bethesda, MD 20892, (301) 435–1042,
zakam2@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Motor System, Pain, and Olfaction.
Date: November 8, 2023.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Kirk Thompson, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5184,
MSC 7844, Bethesda, MD 20892, 301–435–
1242, kgt@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Myalgic
Encephalomyelitis-Chronic Fatigue
Syndrome.
Date: November 8, 2023.
Time: 11:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Roger Janz, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 402–8515, janzr2@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: October 11, 2023.
David W. Freeman,
Supervisory Program Analyst, Office of
Federal Advisory Committee Policy.
[FR Doc. 2023–22770 Filed 10–13–23; 8:45 am]
ddrumheller on DSK120RN23PROD with NOTICES1
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
VerDate Sep<11>2014
17:03 Oct 13, 2023
Jkt 262001
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; AREA/
REAP: Musculoskeletal, Oral, and Skin
Sciences.
Date: November 7, 2023.
Time: 9:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Richard Ingraham, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4116,
MSC 7814, Bethesda, MD 20892, (301) 496–
8551, ingrahamrh@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Fellowships: Musculoskeletal, Rehabilitation
and Skin Sciences.
Date: November 7–8, 2023.
Time: 1:30 p.m. to 8:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Richard Ingraham, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4116,
MSC 7814, Bethesda, MD 20892, (301) 496–
8551, ingrahamrh@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Fellowships: Chemistry, Biochemistry and
Biophysics.
Date: November 8–9, 2023.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Dennis Pantazatos, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 594–2381, dennis.pantazatos@
nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Neurodevelopment and Plasticity.
Date: November 9, 2023.
Time: 12:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
71371
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Vanessa S. Boyce, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Rm. 4185,
MSC 7850, Bethesda, MD 20892, (301) 402–
3726, boycevs@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Research
Enhancement Awards: Molecular Genetics,
Cellular & Cancer Biology.
Date: November 13, 2023.
Time: 1:00 p.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Brian Paul Chadwick,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 594–3586, chadwickbp@
csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Topics in Psychopathology.
Date: November 13, 2023.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Stephanie Christine Nagle
Emmens, Ph.D., Scientific Review Officer,
Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (301) 594–6604,
nagleemmenssc@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Fellowships: Cell Biology, Developmental
Biology, and Bioengineering.
Date: November 14, 2023.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Alexander Gubin, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4196,
MSC 7812, Bethesda, MD 20892, 301–435–
2902, gubina@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Drug Discovery for Aging,
Neurodegenerative and Neurological
Disorders.
Date: November 16–17, 2023.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Contact Person: Kathryn Partlow, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1016D,
E:\FR\FM\16OCN1.SGM
16OCN1
]]>Agencies
[Federal Register Volume 88, Number 198 (Monday, October 16, 2023)]
[Notices]
[Pages 71370-71371]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-22770]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Neurodegenerative Disorders and Aging.
Date: November 7, 2023.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jessica Bellinger, Ph.D., Scientific Review
Administrator, Center for Scientific of Review, National Institutes
of Health, 6701 Rockledge Drive, Room 3158, Bethesda, MD 20892, 301-
827-4446, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Fellowships: Genes, Genomes and Genetics.
Date: November 8-9, 2023.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: The Bethesdan Hotel, 8120 Wisconsin Avenue, Bethesda, MD
20814.
Contact Person: Linda Wagner Jurata, Ph.D., Scientific Review
Officer, The Center for Scientific Review, The National Institutes
of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 496-8032,
[email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Small Business: Biomedical Sensing, Measurement and
Instrumentation.
Date: November 8-9, 2023.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Steven Anthony Ripp, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 594-3010,
[email protected].
[[Page 71371]]
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR Panel: Alzheimer's Disease and its Related Dementias.
Date: November 8-9, 2023.
Time: 9:30 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Mariam Zaka, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 1009J, Bethesda, MD 20892, (301) 435-1042,
[email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Motor System, Pain, and Olfaction.
Date: November 8, 2023.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Kirk Thompson, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5184, MSC 7844, Bethesda, MD 20892, 301-435-
1242, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Myalgic Encephalomyelitis-Chronic Fatigue Syndrome.
Date: November 8, 2023.
Time: 11:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Roger Janz, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892, (301) 402-8515,
[email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: October 11, 2023.
David W. Freeman,
Supervisory Program Analyst, Office of Federal Advisory Committee
Policy.
[FR Doc. 2023-22770 Filed 10-13-23; 8:45 am]
BILLING CODE 4140-01-P
